Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

American Healthcare REIT (AHR) Cost of Revenue (2017 - 2025)

Historic Cost of Revenue for American Healthcare REIT (AHR) over the last 9 years, with Q3 2025 value amounting to $454.5 million.

  • American Healthcare REIT's Cost of Revenue rose 896.66% to $454.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 842.34%. This contributed to the annual value of $1.7 billion for FY2024, which is 1009.0% up from last year.
  • American Healthcare REIT's Cost of Revenue amounted to $454.5 million in Q3 2025, which was up 896.66% from $426.3 million recorded in Q2 2025.
  • Over the past 5 years, American Healthcare REIT's Cost of Revenue peaked at $454.5 million during Q3 2025, and registered a low of $245.1 million during Q1 2021.
  • Its 5-year average for Cost of Revenue is $356.9 million, with a median of $372.5 million in 2023.
  • Within the past 5 years, the most significant YoY rise in American Healthcare REIT's Cost of Revenue was 178324.5% (2021), while the steepest drop was 7072.27% (2021).
  • American Healthcare REIT's Cost of Revenue (Quarter) stood at $277.8 million in 2021, then increased by 29.88% to $360.8 million in 2022, then increased by 6.7% to $385.0 million in 2023, then increased by 11.83% to $430.6 million in 2024, then grew by 5.56% to $454.5 million in 2025.
  • Its last three reported values are $454.5 million in Q3 2025, $426.3 million for Q2 2025, and $432.4 million during Q1 2025.